Bayesian Capital Management, LP Inogen Inc Transaction History

Bayesian Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$112.83 - $239.74 $936,489 - $1.99 Million	-8,300 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$189.1 - $282.92 $907,680 - $1.36 Million	4,800 Added 137.14%	8,300 $2.03 Million
Q2 2018 Aug 14, 2018	BUY	$123.8 - $192.48 $433,300 - $673,680	3,500 New	3,500 $652,000
Q1 2018 May 15, 2018	SELL	$114.22 - $133.22 $467,616 - $545,402	-4,094 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$93.4 - $128.74 $382,379 - $527,061	4,094	4,094 $488,000

143

21M

119K

149K

Ticker INGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 22,866,500
Market Cap $220M
Description
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.